A detailed history of Cim Investment Management Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cim Investment Management Inc holds 31,172 shares of IOVA stock, worth $382,792. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,172
Previous 13,773 126.33%
Holding current value
$382,792
Previous $204,000 22.06%
% of portfolio
0.08%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$7.78 - $14.19 $135,364 - $246,891
17,399 Added 126.33%
31,172 $249,000
Q1 2023

May 16, 2023

BUY
$5.53 - $8.22 $2,632 - $3,912
476 Added 3.58%
13,773 $84,000
Q4 2022

Feb 14, 2023

BUY
$5.62 - $10.0 $74,729 - $132,970
13,297 New
13,297 $84,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.94B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.